Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Genomic regulation of invasion by STAT3 in triple negative breast cancer.

McDaniel JM, Varley KE, Gertz J, Savic DS, Roberts BS, Bailey SK, Shevde LA, Ramaker RC, Lasseigne BN, Kirby MK, Newberry KM, Partridge EC, Jones AL, Boone B, Levy SE, Oliver PG, Sexton KC, Grizzle WE, Forero A, Buchsbaum DJ, Cooper SJ, Myers RM.

Oncotarget. 2017 Jan 31;8(5):8226-8238. doi: 10.18632/oncotarget.14153.

2.

Every transcription factor deserves its map: Scaling up epitope tagging of proteins to bypass antibody problems.

Partridge EC, Watkins TA, Mendenhall EM.

Bioessays. 2016 Aug;38(8):801-11. doi: 10.1002/bies.201600028. Epub 2016 Jun 17.

PMID:
27311628
3.

Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sites.

Savic D, Roberts BS, Carleton JB, Partridge EC, White MA, Cohen BA, Cooper GM, Gertz J, Myers RM.

Genome Res. 2015 Dec;25(12):1791-800. doi: 10.1101/gr.191593.115. Epub 2015 Oct 20.

4.

CETCh-seq: CRISPR epitope tagging ChIP-seq of DNA-binding proteins.

Savic D, Partridge EC, Newberry KM, Smith SB, Meadows SK, Roberts BS, Mackiewicz M, Mendenhall EM, Myers RM.

Genome Res. 2015 Oct;25(10):1581-9. doi: 10.1101/gr.193540.115. Epub 2015 Sep 9.

5.

Distinct properties of cell-type-specific and shared transcription factor binding sites.

Gertz J, Savic D, Varley KE, Partridge EC, Safi A, Jain P, Cooper GM, Reddy TE, Crawford GE, Myers RM.

Mol Cell. 2013 Oct 10;52(1):25-36. doi: 10.1016/j.molcel.2013.08.037. Epub 2013 Sep 26.

6.

Architecture of the human regulatory network derived from ENCODE data.

Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, Min R, Alves P, Abyzov A, Addleman N, Bhardwaj N, Boyle AP, Cayting P, Charos A, Chen DZ, Cheng Y, Clarke D, Eastman C, Euskirchen G, Frietze S, Fu Y, Gertz J, Grubert F, Harmanci A, Jain P, Kasowski M, Lacroute P, Leng JJ, Lian J, Monahan H, O'Geen H, Ouyang Z, Partridge EC, Patacsil D, Pauli F, Raha D, Ramirez L, Reddy TE, Reed B, Shi M, Slifer T, Wang J, Wu L, Yang X, Yip KY, Zilberman-Schapira G, Batzoglou S, Sidow A, Farnham PJ, Myers RM, Weissman SM, Snyder M.

Nature. 2012 Sep 6;489(7414):91-100. doi: 10.1038/nature11245.

7.

Functional analysis of transcription factor binding sites in human promoters.

Whitfield TW, Wang J, Collins PJ, Partridge EC, Aldred SF, Trinklein ND, Myers RM, Weng Z.

Genome Biol. 2012 Sep 26;13(9):R50. doi: 10.1186/gb-2012-13-9-r50.

8.

Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression.

Popławski AB, Jankowski M, Erickson SW, Díaz de Ståhl T, Partridge EC, Crasto C, Guo J, Gibson J, Menzel U, Bruder CE, Kaczmarczyk A, Benetkiewicz M, Andersson R, Sandgren J, Zegarska B, Bała D, Srutek E, Allison DB, Piotrowski A, Zegarski W, Dumanski JP.

Eur J Hum Genet. 2010 May;18(5):560-8. doi: 10.1038/ejhg.2009.230. Epub 2010 Jan 6.

9.

Somatic mosaicism for copy number variation in differentiated human tissues.

Piotrowski A, Bruder CE, Andersson R, Diaz de Ståhl T, Menzel U, Sandgren J, Poplawski A, von Tell D, Crasto C, Bogdan A, Bartoszewski R, Bebok Z, Krzyzanowski M, Jankowski Z, Partridge EC, Komorowski J, Dumanski JP.

Hum Mutat. 2008 Sep;29(9):1118-24. doi: 10.1002/humu.20815.

PMID:
18570184
10.

Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles.

Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S, Diaz de Ståhl T, Menzel U, Sandgren J, von Tell D, Poplawski A, Crowley M, Crasto C, Partridge EC, Tiwari H, Allison DB, Komorowski J, van Ommen GJ, Boomsma DI, Pedersen NL, den Dunnen JT, Wirdefeldt K, Dumanski JP.

Am J Hum Genet. 2008 Mar;82(3):763-71. doi: 10.1016/j.ajhg.2007.12.011. Epub 2008 Feb 14.

11.

Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.

Barter JF, Soong SJ, Hatch KD, Orr JW Jr, Partridge EC, Austin JM Jr, Shingleton HM.

Gynecol Oncol. 1989 Apr;33(1):82-4.

PMID:
2467846
12.

Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate.

Barter JF, Soong SJ, Hatch KD, Orr JW Jr, Partridge EC, Austin JM Jr, Shingleton HM.

Am J Obstet Gynecol. 1987 Nov;157(5):1166-8.

PMID:
2825524

Supplemental Content

Loading ...
Support Center